130 related articles for article (PubMed ID: 17421112)
41. Corticosteroids for treating severe sepsis and septic shock.
McDougal WS
J Urol; 2005 Sep; 174(3):1025. PubMed ID: 16094039
[No Abstract] [Full Text] [Related]
42. Inhibition of 5-lipoxygenase induces cell death in anti-inflammatory fatty acid-treated HL-60 cells.
Gillis RC; Daley BJ; Enderson BL; Karlstad MD
JPEN J Parenter Enteral Nutr; 2004; 28(5):308-14. PubMed ID: 15449569
[TBL] [Abstract][Full Text] [Related]
43. [Management of neonatal sepsis and septic shock].
Wojsyk-Banaszak I; Szczapa J
Przegl Epidemiol; 2006; 60(1):119-26. PubMed ID: 16758750
[TBL] [Abstract][Full Text] [Related]
44. [Is there a reliable immunotherapy in infection?].
Grimminger F; Mayer K; Seeger W
Internist (Berl); 1997 Jun; 38(6):541-52. PubMed ID: 9264999
[No Abstract] [Full Text] [Related]
45. [Pancreatitis and nutrition. Significance of the gastrointestinal tract and nutrition for septic complications].
Foitzik T
Zentralbl Chir; 2001 Jan; 126(1):4-9. PubMed ID: 11227293
[TBL] [Abstract][Full Text] [Related]
46. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats.
Palombo JD; DeMichele SJ; Boyce PJ; Lydon EE; Liu JW; Huang YS; Forse RA; Mizgerd JP; Bistrian BR
Crit Care Med; 1999 Sep; 27(9):1908-15. PubMed ID: 10507617
[TBL] [Abstract][Full Text] [Related]
47. Taurine Concentrations Decrease in Critically Ill Patients With Shock Given Enteral Nutrition.
Vermeulen MA; van Stijn MF; Visser M; Lemmens SM; Houdijk AP; van Leeuwen PA; Oudemans-van Straaten HM
JPEN J Parenter Enteral Nutr; 2016 Feb; 40(2):264-72. PubMed ID: 25587009
[TBL] [Abstract][Full Text] [Related]
48. [Management of septic shock and acquired respiratory distress syndrome in pediatric cancer patients].
Bindl L; Nicolai T
Klin Padiatr; 2005 Nov; 217 Suppl 1():S130-42. PubMed ID: 16288359
[TBL] [Abstract][Full Text] [Related]
49. Reduced mortality from septic shock--lessons for the future.
Cohen NH
Crit Care Med; 1998 Dec; 26(12):1956-8. PubMed ID: 9875902
[No Abstract] [Full Text] [Related]
50. HLA-DR monitoring in the intensive care unit--more than a tool for the scientist in the laboratory?
Flohé S; Scholz M
Crit Care Med; 2009 Oct; 37(10):2849-50. PubMed ID: 19865013
[No Abstract] [Full Text] [Related]
51. [What is evidence-based?].
Gerlach H
Krankenpfl J; 2005; 43(1-3):54-5. PubMed ID: 15912843
[No Abstract] [Full Text] [Related]
52. Management of the critically ill patient with severe sepsis.
Vincent JL; Preiser JC
J Chemother; 1999 Dec; 11(6):524-9. PubMed ID: 10678795
[TBL] [Abstract][Full Text] [Related]
53. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
[TBL] [Abstract][Full Text] [Related]
54. Early goal-directed therapy of septic shock: we honestly remain skeptical.
Peake S; Webb S; Delaney A
Crit Care Med; 2007 Mar; 35(3):994-5; author reply 995. PubMed ID: 17421118
[No Abstract] [Full Text] [Related]
55. Blood and plasma treatments: high-volume hemofiltration--a global view.
Honoré PM; Joannes-Boyau O; Gressens B
Contrib Nephrol; 2007; 156():371-86. PubMed ID: 17464148
[TBL] [Abstract][Full Text] [Related]
56. Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: hyperglycemia and diabetes mellitus.
Vaquerizo Alonso C; Grau Carmona T; Juan Díaz M;
Nutr Hosp; 2011 Nov; 26 Suppl 2():46-9. PubMed ID: 22411519
[TBL] [Abstract][Full Text] [Related]
57. Elevated nucleosome levels in systemic inflammation and sepsis.
Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
[TBL] [Abstract][Full Text] [Related]
58. [Progress in therapy of infection].
Müller-Werdan U; Buerke M; Werdan K
Internist (Berl); 2003 Dec; 44(12):1531-40. PubMed ID: 14689196
[No Abstract] [Full Text] [Related]
59. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R
JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952
[TBL] [Abstract][Full Text] [Related]
60. Malnutrition, injury, and the host immune response: nutrient substitution.
Gallagher HJ; Daly JM
Curr Opin Gen Surg; 1993; ():92-104. PubMed ID: 7584022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
